Xiansheng Pharmaceutical (02096) announced that on April 12, 2024, the company spent 10.9087 million...
According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on April 12, 2024, the company spent HK$10.9087 million to repurchase 2.08 million shares, with a repurchase price of HK$5.22-5.28 per share.